![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TMEM57 |
Gene summary for TMEM57 |
![]() |
Gene information | Species | Human | Gene symbol | TMEM57 | Gene ID | 55219 |
Gene name | macoilin 1 | |
Gene Alias | MACOILIN | |
Cytomap | 1p36.11 | |
Gene Type | protein-coding | GO ID | GO:0006935 | UniProtAcc | Q8N5G2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
55219 | TMEM57 | HTA11_99999970781_79442 | Human | Colorectum | MSS | 1.44e-19 | 3.40e-01 | 0.294 |
55219 | TMEM57 | HTA11_99999965062_69753 | Human | Colorectum | MSI-H | 1.89e-11 | 9.26e-01 | 0.3487 |
55219 | TMEM57 | HTA11_99999965104_69814 | Human | Colorectum | MSS | 4.10e-17 | 4.74e-01 | 0.281 |
55219 | TMEM57 | HTA11_99999971662_82457 | Human | Colorectum | MSS | 2.14e-33 | 6.00e-01 | 0.3859 |
55219 | TMEM57 | HTA11_99999973899_84307 | Human | Colorectum | MSS | 5.79e-04 | 1.70e-01 | 0.2585 |
55219 | TMEM57 | HTA11_99999974143_84620 | Human | Colorectum | MSS | 1.73e-12 | 3.04e-01 | 0.3005 |
55219 | TMEM57 | P1T-E | Human | Esophagus | ESCC | 4.79e-10 | 5.59e-01 | 0.0875 |
55219 | TMEM57 | P2T-E | Human | Esophagus | ESCC | 7.57e-46 | 8.68e-01 | 0.1177 |
55219 | TMEM57 | P4T-E | Human | Esophagus | ESCC | 3.09e-27 | 5.55e-01 | 0.1323 |
55219 | TMEM57 | P5T-E | Human | Esophagus | ESCC | 4.06e-13 | 2.39e-01 | 0.1327 |
55219 | TMEM57 | P8T-E | Human | Esophagus | ESCC | 5.37e-27 | 4.89e-01 | 0.0889 |
55219 | TMEM57 | P9T-E | Human | Esophagus | ESCC | 1.67e-09 | 2.11e-01 | 0.1131 |
55219 | TMEM57 | P10T-E | Human | Esophagus | ESCC | 6.19e-27 | 5.11e-01 | 0.116 |
55219 | TMEM57 | P11T-E | Human | Esophagus | ESCC | 3.95e-15 | 5.75e-01 | 0.1426 |
55219 | TMEM57 | P12T-E | Human | Esophagus | ESCC | 2.14e-24 | 4.82e-01 | 0.1122 |
55219 | TMEM57 | P15T-E | Human | Esophagus | ESCC | 1.19e-24 | 5.24e-01 | 0.1149 |
55219 | TMEM57 | P16T-E | Human | Esophagus | ESCC | 1.03e-18 | 2.68e-01 | 0.1153 |
55219 | TMEM57 | P17T-E | Human | Esophagus | ESCC | 1.26e-16 | 4.41e-01 | 0.1278 |
55219 | TMEM57 | P19T-E | Human | Esophagus | ESCC | 2.21e-02 | 4.91e-01 | 0.1662 |
55219 | TMEM57 | P20T-E | Human | Esophagus | ESCC | 1.48e-22 | 3.72e-01 | 0.1124 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Stomach | WIM | ![]() |
Stomach | SIM | ![]() |
Liver | NAFLD | ![]() |
Liver | Cirrhotic | ![]() |
Liver | HCC | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TMEM57 | SNV | Missense_Mutation | novel | c.1085N>A | p.Ser362Asn | p.S362N | Q8N5G2 | protein_coding | tolerated(0.49) | benign(0) | TCGA-A7-A0CD-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
TMEM57 | SNV | Missense_Mutation | novel | c.455G>T | p.Arg152Leu | p.R152L | Q8N5G2 | protein_coding | deleterious(0) | possibly_damaging(0.719) | TCGA-A7-A0DB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
TMEM57 | SNV | Missense_Mutation | c.1244C>T | p.Ser415Leu | p.S415L | Q8N5G2 | protein_coding | tolerated(0.82) | benign(0.024) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
TMEM57 | SNV | Missense_Mutation | c.1510G>A | p.Glu504Lys | p.E504K | Q8N5G2 | protein_coding | deleterious(0.01) | benign(0.146) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TMEM57 | SNV | Missense_Mutation | novel | c.1846G>A | p.Glu616Lys | p.E616K | Q8N5G2 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TMEM57 | SNV | Missense_Mutation | c.1256N>T | p.Arg419Leu | p.R419L | Q8N5G2 | protein_coding | deleterious(0.04) | probably_damaging(0.98) | TCGA-AN-A0AT-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
TMEM57 | SNV | Missense_Mutation | c.1831N>G | p.Lys611Glu | p.K611E | Q8N5G2 | protein_coding | deleterious(0.04) | probably_damaging(0.998) | TCGA-AO-A03R-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
TMEM57 | SNV | Missense_Mutation | c.484N>T | p.Pro162Ser | p.P162S | Q8N5G2 | protein_coding | deleterious(0.04) | probably_damaging(0.961) | TCGA-AQ-A04H-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | taxotere | SD | |
TMEM57 | SNV | Missense_Mutation | c.838N>C | p.Asp280His | p.D280H | Q8N5G2 | protein_coding | deleterious(0.04) | probably_damaging(0.983) | TCGA-B6-A0RT-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
TMEM57 | SNV | Missense_Mutation | c.277C>A | p.Leu93Met | p.L93M | Q8N5G2 | protein_coding | deleterious(0.02) | possibly_damaging(0.897) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |